SML1630

Bendazac

≥98% (HPLC)

• Synonym(e): Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• Empirische Formel (Hill-System): C₁₆H₁₄N₂O₃
• CAS-Nummer: 20187-55-7
• Molekulargewicht: 282.29
• NACRES: NA.77
• PubChem Substance ID: 329825514
• UNSPSC Code: 12352200
• EC Number: 243-569-2
• MDL number: MFCD00866158
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 200
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: soluble ≥1 mg/mL, methanol: soluble ≥1 mg/mL
• storage temp.: 2-8°C
• SMILES string: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• InChI key: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• Gene Information: human ... XDH(7498)

Beschreibung

Biochem/physiol Actions

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

Bendazac is a non-steroidal anti-inflammatory drug used for joint and muscular pain.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• WGK: WGK 3